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Abstract
Event-related potential (ERP) components have been used to assess cognitive functions in patients with psychotic
illness. Evidence suggests that among patients with psychosis there is a distinct heritable neurophysiologic phenotypic
subtype captured by impairments across a range of ERP measures. In this study, we investigated the genetic basis of
this “globally impaired” ERP cluster and its relationship to psychosis and cognitive abilities. We applied K-means
clustering to six ERP measures to re-derive the globally impaired (n= 60) and the non-globally impaired ERP clusters
(n= 323) in a sample of cases with schizophrenia (SCZ= 136) or bipolar disorder (BPD= 121) and healthy controls (n
= 126). We used genome-wide association study (GWAS) results for SCZ, BPD, college completion, and childhood
intelligence as the discovery datasets to derive polygenic risk scores (PRS) in our study sample and tested their
associations with globally impaired ERP. We conducted mediation analyses to estimate the proportion of each PRS
effect on severity of psychotic symptoms that is mediated through membership in the globally impaired ERP.
Individuals with globally impaired ERP had signiﬁcantly higher PANSS-positive scores (β= 3.95, P= 0.005). The SCZ-
PRS was nominally associated with globally impaired ERP (unadjusted P= 0.01; R2= 3.07%). We also found a
signiﬁcant positive association between the college-PRS and globally impaired ERP (FDR-corrected P= 0.004; R2=
6.15%). The effect of college-PRS on PANSS positivity was almost entirely (97.1%) mediated through globally impaired
ERP. These results suggest that the globally impaired ERP phenotype may represent some aspects of brain physiology
on the path between genetic inﬂuences on educational attainment and psychotic symptoms.
Introduction
In recent years, traditional psychiatric diagnostic con-
structs have been increasingly challenged. This is parti-
cularly evident in psychotic spectrum disorders such as
schizophrenia (SCZ), schizoaffective disorder (SA), and
psychotic bipolar disorder (BPD). These disorders overlap
substantially in symptoms, neurobiology, cognitive fea-
tures, treatment response, and liability risk factors1,2.
Moreover, large-scale genetic studies have consistently
found overlap in susceptibility across BPD, SA, SCZ, and
related phenotypes3–5. In line with shared genetic sus-
ceptibility, the endophenotype–biomarker literatures on
BPD–SCZ indicate differences in degree, rather than
differences in kind, across various domains of brain
function, both in patients and in their clinically unaffected
relatives6–12. These observations challenge the traditional
dichotomous model of SCZ and BPD and support a
dimensional approach to understanding how genetic and
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neurobiological underpinnings cut across diagnostic
boundaries.
Auditory event-related potential (ERP) components—
including P50 sensory gating, N1, P2, and P3—have been
extensively investigated in the psychoses and are putative
endophenotypes for psychotic spectrum disorders7,13–17.
Each of these ERP components measures speciﬁc aspects
of brain function and is reliably quantiﬁable across diverse
clinical and laboratory settings11,18. P50 sensory gating
probes inhibitory mechanisms thought to be crucial for
protecting the brain from information overload19.
Response to S1 stimulus assesses basic brain functions
associated with auditory perception20. N1 ERP indexes
sensory processing at the level of auditory cortex17. P2
and P3 components are associated with higher-order
cognitive processes relevant to attention, working mem-
ory, and information processing speed21,22 (see Supple-
mentary Information for details on ERPs). In twin
analyses, we have shown that ERP phenotypes are heri-
table and genetically correlated with BPD and SCZ8,9,15.
We have also identiﬁed multivariate clusters of ERP
phenotypes that appear to aggregate among individuals
with psychotic BPD and SCZ, independent of diagnosis23.
In that study, various domains of brain function, ranging
from the early pre-attentive stage of information proces-
sing to higher complex cognitive processes (including
P50 sensory gating, gamma band response, mismatch
negativity, and the N1, P2, and P3 ERPs), were included to
allow us to empirically derive homogenous subgroups
based on these features. One of the clusters was termed
“globally impaired” because this group of subjects exhib-
ited functional abnormalities on all of these ERP mea-
sures. Such data-driven clustering holds promise for
parsing the neurobiological and genetic heterogeneity of
psychotic illness, and the analysis of phenotypes based on
these clusters may enhance the power of genetic asso-
ciation analyses24,25. Importantly, the neuro-clusters
identiﬁed in our study resembled the “Biotypes” recently
reported by the Bipolar-Schizophrenia Network for
Intermediate Phenotypes (BSNIP) consortium10, even
though somewhat different biomarker panels were used in
each study. Taken together, these results represent a
diagnosis-free approach to integrate information across
biomarkers, yielding neurobiologically distinct subgroups,
and provide evidence supporting the potential role of
neurobiological classiﬁcation in differentiating individuals
with psychotic disorders. The “globally impaired” ERP
cluster identiﬁed in our prior work was found to be
associated with psychotic illness and symptoms across
diagnostic boundaries, but its genetic relationship to
psychotic illness is unclear.
Findings from well-powered genome-wide association
study (GWAS) indicate that psychiatric disorders are
highly polygenic, reﬂecting the inﬂuence of thousands of
common variants (single-nucleotide polymorphisms
(SNPs)) of small effect. Although the individually modest
effects of common variants make them uninformative as
risk biomarkers, genome-wide polygenic risk scores
(PRSs), which aggregate the effects of multiple SNPs from
GWAS, can capture a substantial liability to disease risk26.
The PRS for SCZ and BPD could be used to examine the
degree to which multiple risk loci for psychotic illness
overlap with those inﬂuencing the globally impaired ERP
cluster, and such polygenic overlap could provide support
for the globally impaired ERP as a putative endopheno-
type for psychotic illness.
ERP components have been used to assess cognitive
functions in patients with psychotic illness. Although
cognitive impairment is considered as a core feature of
SCZ27 and psychotic BPD28,29, the relationship between
cognitive performance and SCZ–BPD disorders is com-
plex and controversial. Several epidemiological studies
have reported low cognitive ability and poor school per-
formance as risk factors for SCZ and BPD30–32. However,
other studies have found a higher risk of developing
psychotic illness among individuals with high levels of
cognitive performance and creativity33–36. In addition,
recent analysis of cross-trait genetic correlation found a
positive genetic correlation between psychotic illness and
higher educational attainment37–40, which has been used
as a proxy for adolescent and young adult cognitive ability
in genetic research41,42. PRSs for both SCZ and BPD were
also reported to be highly positively associated with
creativity and educational attainment43. Therefore, it is
worthwhile to further examine the genetic relationship
between cognitive ability and ERPs, an electro-
physiological index of cognitive functions in psychotic
illness.
In the present study, we ﬁrst used a new sample with a
similar panel of ERP phenotypes as those used in our
previous study, performing K-means multivariate analyses
to derive empirical clusters and see if we could replicate
the previously derived neuro-clusters and the association
between globally impaired ERP and psychotic symp-
toms23. We then constructed genome-wide PRSs for
psychiatric and cognitive phenotypes, including SCZ,
BPD, educational attainment, and childhood intelligence,
to examine the shared genetic components between
globally impaired neuro-cluster and each psychiatric or
cognitive phenotype. Finally, we used a novel approach
combining polygenic proﬁling and causal mediation
methods to test the hypothesis that the “globally
impaired” ERP proﬁle represents an intermediate pheno-
type that mediates genetic inﬂuences on the symptoma-
tology of SCZ and BPD. We performed causal mediation
analyses to explore whether the “globally impaired proﬁle”
is a mediator between PRS and speciﬁc clinical features.
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Methods
Study sample
The study sample consisted of 258 cases (SCZ= 136
and psychotic BPD= 122) and 125 healthy controls (prior
to genetic quality control procedures). Cases were
recruited from McLean Hospital, and healthy controls
were recruited through local advertisements. All partici-
pants were assessed with the Structured Clinical Interview
for DSM Disorders (SCID-I)44. All participants were of
self-reported European ancestry, between 18 and 65 years
of age, with no history of neurological disorders, no his-
tory of head injury, no substance abuse (except nicotine)
or dependence in the preceding 12 months, normal
hearing conﬁrmed by audiometric testing, and normal
intelligence based on the North American Adult Reading
Test (NAART). All cases did not receive ECT treatment
in the preceding 12 months, and were sufﬁciently stable to
participate on an outpatient basis. All controls had no
history of psychotic and mood disorders themselves or in
a ﬁrst-degree relative. Because of possible genetic overlap
between psychosis and mood disorders, the healthy con-
trol group included only those free of mood disorders to
optimize power to detect genetic risk factors.
This study was approved by the institutional review
board at McLean Hospital. Written informed consent was
obtained from all participants after fully explaining the
aims and procedures of the studies.
Clinical assessments
All participants completed the SCID-IV diagnostic
interview, the Snaith–Hamilton Pleasure Scale (SHPS)45,
and the Mood and Anxiety Symptom Questionnaire
(MASQ)46. Demographic (age, sex, years of education,
smoking status) and medication information were also
obtained from participants. Treatment with antipsychotic
medication was quantiﬁed in terms of chlorpromazine
(CPZ) equivalents47. Among the 258 cases, 161 (SCZ n=
77, BPD n= 84) had data on Positive and Negative Syn-
drome Scale (PANSS) scores48, 243 (SCZ n= 121, BPD n
= 122) had data on Young Mania Rating Scale (YMRS)
scores49, and 138 (SCZ n= 66, BPD n= 77) had data on
Multnomah Community Ability Scale (MCAS) scores50.
There was no observed association between globally
impaired ERP and missing data on each of the rating
scales (all P > 0.20).
Electrophysiological phenotypic measures
All participants completed the following tasks: an
auditory dual-click paradigm51 and an auditory “oddball”
paradigm52. We applied the same electroencephalogram
(EEG) recording and processing procedures as described
previously15,23. Brieﬂy, EEG was recorded using the Bio-
Semi Active Two system at a digitization rate of 512 Hz,
with a bandpass of DC–104 Hz and a Common Mode
Sense as the reference (PO2 site, parieto-occipital elec-
trode 2) using an 18-channel electrode cap. Blinks and eye
movements were monitored through electrodes placed on
the left temple and above and below the left eye. The EEG
data were re-referenced off-line to the averaged mastoid.
Subjects were not allowed to smoke for a minimum of
40min prior to the recordings. P50 sensory gating and
response to S1 stimulus were elicited using the dual-click
paradigm. The P50 sensory gating ERP was reported at
the Cz site (central (C), midline of the head (z)) and cal-
culated as a ratio (S2/S1) × 100, where higher ratios reﬂect
more impairment. N1 and P2 amplitude ERPs were eli-
cited by the response to the standard stimuli in the
auditory Oddball paradigm and reported at the Cz site,
whereas P3 amplitude and latency ERPs were elicited by
the response to the target stimuli in the Oddball paradigm
reported at the Pz site (parietal (P)) (see Supplementary
Methods for detail).
K-means cluster analyses
As in our previous study23, we included all participants
(cases and healthy controls) in the analysis to empirically
identify homogeneous subgroups of individuals who share
similar neurophysiological proﬁles, regardless of diag-
nostic status. Individuals were clustered into three distinct
subgroups using the K-means algorithm53 implemented
in JMP (version 12.0, SAS Institute Inc.), according to six
ERP measures: P50 sensory gating, amplitude of S1
response, N1 amplitude, P2 amplitude, P3 amplitude, and
P3 latency. A globally impaired cluster, an intermediate
cluster, and a high cognitive functioning cluster were
empirically derived (Supplementary Table S2). The
number of clusters was initially set at 3, based on our
previous analysis23. We also applied a V-fold cross-vali-
dation method54 to a range of numbers of clusters (from 2
to 5) and identiﬁed 3 as the optimal value of K for K-
means.
In our analyses, individuals in the globally impaired
cluster were compared to those in the other two clusters
(globally impaired (n= 60) vs. non-globally impaired (n=
323)). We treated the ERP clusters as categories based on
our hypothesis that the globally impaired ERP, in parti-
cular, may be a useful phenotype for genetic studies.
Genotyping and quality control
Genomic DNA from blood samples was extracted by
standard procedures at the Massachusetts General Hos-
pital Center for Genomic Medicine. Genotyping was
performed at the Broad Institute using the Illumina Inﬁ-
nium OmniExpress array (Illumina Inc., San Diego, CA,
USA). The quality control (QC) procedures have been
described elsewhere14. Brieﬂy, we excluded 9 individuals
with discordant sex information, missing genotype rate
>5% or heterozygosity rate >3 SD, shared inﬂammatory
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bowel disease >0.125, or non-European ancestry based on
principal component analyses. We removed ~45,000
SNPs on the X or Y chromosome, minor allele frequency
<0.05, call rate <98%, and P < 1 × 10E−6 for deviation
from Hardy–Weinberg equilibrium. The QC steps were
carried out with PLINK55 and resulted in a total of
374 subjects with genotype data on 664,907 autosomal
SNPs.
We then performed genotype imputation, using the
phased haplotypes from the 1000 Genomes Project
dataset as the reference panel. Prephasing and imputation
was done with SHAPEIT and IMPUTE256,57. The impu-
tation was performed with the default parameters of the
software. The ﬁnal imputed dataset consisted of 9.7 mil-
lion autosomal SNPs.
Statistical analyses
Phenotypic association analyses
T-tests, chi-square tests, or multivariable linear regres-
sion analyses were used (STATA version 12; Stata Corp.,
College Station, TX) to compare the demographic and
clinical characteristics between the globally impaired ERP
group and the non-globally impaired ERP group.
PRS association analyses
We used GWAS summary statistics for SCZ58 and
BPD59 from the Psychiatric Genomics Consortium (PGC),
educational attainment (college completion)41 from the
Social Science Genetic Association Consortium (SSGAC),
and childhood intelligence60 from the Childhood Intelli-
gence Consortium (CHIC) as the discovery datasets to
derive genome-wide PRSs61 for each of the above psy-
chiatric or cognitive phenotypes in the study sample. The
SCZ discovery sample consisted of 46 non-overlapping
case–control samples (33,356 cases and 43,724 controls)
and 3 family-based samples (1396 parent
affected–offspring trios). The BPD discovery sample
included 11 case–control samples (7481 cases and 9250
controls). The college completion discovery sample were
combined from 42 GWAS samples (22,475 college and
78,594 non-college), and 95.8% of the individuals were
older than 30 years. The childhood intelligence discovery
sample consisted of 6 cohorts with a total of 12,411
children aged 6 to 18 years. All subjects in the discovery
samples were of European ancestry. There were no
overlapping individuals between these discovery samples
and our study sample.
To account for only independent association signals
from these discovery GWAS, we applied a linkage dis-
equilibrium (LD) clumping procedure to each discovery
dataset, in which we retained the SNP with smallest P
value in each 250 kb window and removed all those in LD
(r2 > 0.1) with this SNP. We also excluded the major
histocompatibility complex region between 26 and 33Mb
on chromosome 6 when calculating the PRSs, because of
the complex haplotype and LD structure in this region.
For each psychiatric or cognitive phenotype, we used ﬁve
different association P value thresholds (PTs)—0.001, 0.01,
0.05, 0.1, and 0.5—to select index SNPs from the clumped
independent SNPs for calculating the PRSs. For each
individual, we calculated the PRS for each psychiatric or
cognitive phenotype by summing the risk allele counts of
the index SNPs, weighted by the log of their association
odds ratios (for SCZ, BPD, and college completion) or the
beta coefﬁcients (for childhood intelligence) estimated
from the discovery GWAS results.
We used PRSice v1.2362 to calculate the PRSs and test
the association between each PRS and the globally
impaired ERP group. Associations were tested using
logistic regression models including the top 3 principal
components (PCs) of ancestry from the EIGENSTRAT
analysis63 as covariates. We adjusted for the ﬁrst 3 PCs
because the 4th PC offers very little increase (<2%) in the
total explained variance. Wald test P values and Nagelk-
erke’s R2s are reported. We performed the above PRS
association analyses on the entire study sample and then
repeated the same analyses on the case-only subsample.
We used POLYGENESCORE software in R64 to calculate
statistical power for the association between each PRS and
the globally impaired ERP (see Supplementary Methods.)
Causal mediation analyses
Relationship between PRS, globally impaired ERP, and
PANSS-positive score
For each psychiatric or cognitive phenotype that gave
evidence of PRS association with globally impaired ERP,
we selected the PRS with a P value threshold that showed
the strongest association, and examined its relationship
with globally impaired ERP and PANSS-positive score in
our study sample. We performed regression-based causal
mediation analyses to examine whether globally impaired
ERP might play a crucial mediating role in the polygenic
effect on psychotic symptoms.
In these analyses we estimated the direct effect of each
associated PRS (highest vs. lowest quartile) on the
PANSS-positive score and the indirect effect mediated by
globally impaired ERP (binary, globally impaired vs. non-
globally impaired), adjusting for the top 3 PCs of ancestry,
age, sex, daily CPZ equivalent dose of antipsychotics, and
current smoking status at the time of EEG recording,
which were potential exposure–mediator,
exposure–outcome, or mediator–outcome confounders.
The proportion mediated was obtained by dividing the
estimated indirect effect by the estimated total effect, as
an index of the degree of mediation. This method is based
on the counterfactual framework for causal inference65,
which is an extension of traditional regression-based
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mediation approaches66, allowing binary mediators and
outcomes as well as exposure–mediator interactions67.
Relationship between PRS, diagnosis, and globally impaired
ERP
Because PRS for any of the psychiatric or cognitive
phenotypes may be associated with the diagnosis of psy-
chotic illness5,38, it is possible that the observed rela-
tionship between a PRS and globally impaired ERP is a
secondary consequence of the PRS effect on psychotic
illness. To understand whether the effect of any associated
PRS on globally impaired ERP is mediated through “case
vs. control status” (i.e., presence vs. absence of psychotic
illness) or through one speciﬁc major mental illness (SCZ
vs. BPD among cases), we also performed mediation
analyses to understand the relationships between PRS,
diagnosis, and Globally impaired ERP (see Supplementary
Methods).
Sensitivity analyses
Finally, we conducted sensitivity analyses to evaluate the
robustness of the above mediation analyses to unmea-
sured confounding (see Supplementary Methods). All
mediation analyses were performed using the PARAMED
module in STATA68. We used bootstrap procedures with
200 replications to compute a 95% bias-corrected boot-
strap conﬁdence interval (95% BCCI) for the direct and
indirect effects.
Results
Phenotypic associations with globally impaired ERP
The demographic and clinical characteristics of the
globally impaired ERP and the non-globally impaired ERP
are presented in Table 1. In the analysis of all participants,
the globally impaired cluster consisted of primarily SCZ
or BPD cases (91.7%, which included 48.3% of SCZ cases,
43.3% of BPD cases, vs. 8.3% of controls). The small dif-
ference between the proportion of the two disorder
groups classiﬁed as either globally impaired was not sig-
niﬁcant. Individuals in the globally impaired cluster were
signiﬁcantly older (P= 0.007) and were more likely to be
current smokers (P= 0.005).
In the analysis restricted to cases only, there was no
signiﬁcant difference in age or other demographic vari-
ables between the two ERP clusters. However, SCZ/BPD
cases in the globally impaired cluster had signiﬁcantly
higher PANSS-positive scores than those in the non-
globally impaired cluster (mean (SD): 19.88 (7.49) vs.
16.13 (6.98); P= 0.007), and these differences persisted
after adjusting for age, sex, daily chlorpromazine equiva-
lent dose of antipsychotics, and smoking status at the time
of EEG recording (multivariable linear regression: β=
3.95, P= 0.005).
Supplementary Table S1 presents demographic and
clinical information for the study sample by diagnostic
group.
PRS association analyses
Results of PRS associations between the globally
impaired ERP cluster and SCZ-PRS, BPD-PRS, college-
PRS, and childhood intelligence-PRS including all subjects
are presented in Fig. 1a and Supplementary Table S3a.
Results restricted to cases only are presented in Fig. 1b
and Supplementary Table S3b. In the full sample analyses,
the SCZ-PRS with a P value threshold of 0.001 (SCZ-
PRSPT=0.001) was signiﬁcantly positively associated with
risk of globally impaired ERP (unadjusted P= 0.01; R2=
3.07%). This association approached signiﬁcance (false
discovery rate (FDR)-corrected P= 0.06) even after cor-
recting for multiple testing (n= 20) by the FDR q-value
method69,70. In the analyses restricted to cases only,
results were not signiﬁcant but were in the same direction
(unadjusted P= 0.09, R2= 1.76%; FDR-corrected P=
0.17). For the BPD-PRS, no signiﬁcant associations were
found with the globally impaired ERP cluster in either the
whole sample or the case-only subsample.
In the full sample analyses, we found a signiﬁcant
positive association between the college-PRS and the
globally impaired cluster across all ﬁve P value thresholds
(unadjusted P values range from 2.95E−04 to 0.05, see
Supplementary Table S3a), such that alleles associated
with higher educational attainment were associated with
being in the globally impaired cluster. After multiple
testing correction, this association remained signiﬁcant
for the college-PRS with a PT= 0.01 (college-PRSPT=0.01,
FDR-corrected P= 0.004; R2= 6.15%). We also observed
a nominally positive association between the childhood
intelligence-PRS with PT= 0.05 and the globally impaired
cluster (unadjusted P= 0.02, R2= 2.40%; FDR-corrected
P= 0.08). In the case-only subsample, we again found a
signiﬁcant positive association between the college-
PRSPT=0.01 and globally impaired ERP membership
(unadjusted P= 0.004; FDR-corrected P= 0.04; R2=
5.11%; see Supplementary Table S3b) and a positive
association between the childhood intelligence-
PRSPT=0.05 and globally impaired ERP (unadjusted P=
0.01; FDR-corrected P= 0.06; R2= 3.70%).
Results of the power analysis for detecting the associa-
tion between each PRS and the globally impaired ERP are
presented in Supplementary Tables S4a-4d. These results
may mitigate concerns that the differential associations
across PRS are due to difference in the power of GWAS
for each phenotype.
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Mediation analyses
Relationship between SCZ-PRS, globally impaired ERP, and
PANSS-positive score
As noted above, the SCZ-PRS with a P value threshold
of 0.001 (SCZ-PRSPT=0.001) was nominally associated with
the globally impaired cluster, and this association
approached signiﬁcance after correcting for multiple
testing. Because of the observed association between
globally impaired ERP and PANSS-positive scores among
cases, we further examined whether SCZ-PRSPT=0.001 is
also associated with PANSS-positive score and whether
this relationship is mediated by globally impaired ERP
(Fig. 2). The estimated direct and indirect effects betas
were 2.68 (95% BCCI: −0.37, 5.52) and 0.27 (95% BCCI:
Table 1 Demographic and clinical characteristics of globally impaired and non-globally impaired clusters
Phenotype characteristics All subjects
Globally impaired ERP Non-globally impaired ERP P value
Diagnosis X2= 19.11, P= 7.07E−05
SCZ, N (%) 29 (48.3) 107 (33.1)
BPD, N (%) 26 (43.3) 96 (29.7)
Unaffected, N(%) 5 (8.3) 120 (37.2)
Sex X2= 0.18, P= 0.68
Female, N (%) 30 (50.0) 171 (52.9)
Age (years), mean (SD) 43.58 (14.68) 38.41 (13.25) t-test, P= 0.007
Education (years), mean (SD) 14.58 (2.22) 14.98 (2.27) t-test, P= 0.22
Current smoker, N (%) 24 (42.1) 77 (24.2) X2= 7.86, P= 0.005
MASQ total, mean (SD) 130.53 (37.62) 121.27 (36.70) t-test, P= 0.11MLR, P= 0.62
SHPS, mean (SD) 1.84 (2.87) 1.09 (1.92) t-test, P= 0.02 MLR, P= 0.29
Cases with SCZ or BPD
Diagnosis X2 < 0.0001, P= 1.00
SCZ, N (%) 29 (52.7) 107 (52.7)
BPD, N (%) 26 (47.3) 96 (47.3)
Sex X2= 2.47, P= 0.12
Female, N (%) 26 (47.3) 120 (59.1)
Age (years), mean (SD) 45.02 (14.39) 41.38 (12.68) t-test, P= 0.07
Education (years), mean (SD) 14.38 (2.2) 14.62 (2.2) t-test, P= 0.50
Current smoker, N (%) 24 (46.2) 69 (34.3) X2= 2.48, P= 0.12
Age of onset (years), mean (SD) 22.35 (8.4) 22.87 (8.3) t-test, P= 0.70
CPZ equivalent dosage (mg), mean (SD) 286.06 (336.70) 376.62 (508.10) t-test, P= 0.24
PANSS positive total, mean (SD) 19.88 (7.49) 16.13 (6.98) t-test, P= 0.007MLR, P= 0.005
PANSS negative total, mean (SD) 13.18 (7.46) 12.22 (5.64) t-test, P= 0.42MLR, P= 0.31
PANSS general total, mean (SD) 32.82 (8.61) 30.28 (9.56) t-test, P= 0.17MLR, P= 0.11
MCAS total, mean (SD) 44.54 (8.19) 46.83 (5.71) t-test, P= 0.09MLR, P= 0.28
YMRS total, mean (SD) 7.81 (12.22) 8.64 (11.19) t-test, P= 0.64MLR, P= 0.91
MASQ total, mean (SD) 134.93 (36.9) 136.49 (38.6) t-test, P= 0.81MLR, P= 0.83
SHPS, mean (SD) 2.02 (2.96) 1.65 (2.3) t-test, P= 0.39MLR, P= 0.31
X2 is chi-square statistic
t-test is two-sample t-test for equal means
MLR is multivariable linear regression for the association between clinical assessments and globally impaired ERP, adjusting for: (1) age, sex, case–control status, and
current smoking status for all subjects; or (2) age, sex, daily chlorpromazine equivalent dose of antipsychotics, and current smoking status for cases with SCZ or BPD
All bold values are signiﬁcant at P < 0.05
All tests are two sided
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−0.34, 1.23), respectively. The proportion of estimated
mediating effect of globally impaired ERP on the total
effect of SCZ-PRS on PANSS-positive score was small
(9.1%). Adding an exposure–mediator interaction term
did not substantially change the effect estimates (direct
effect β= 2.30 (95% BCCI: −0.82, 5.18); indirect effect β
= 0.44 (95% BCCI: −0.63, 1.92)). The minimal effect of
including the interaction term suggests that
exposure–mediator interaction did not appear to be
substantial71.
Relationship between college-PRS, globally impaired ERP,
and PANSS-positive score
We found a signiﬁcant positive association, even after
multiple testing correction, between the globally impaired
cluster and the college-PRS at the P value threshold of
0.01. We further examined whether college-PRSPT=0.01 is
also associated with PANSS-positive score and whether
this relationship is mediated by globally impaired ERP.
Results of the analysis with globally impaired ERP cluster
as a mediator between college-PRSPT=0.01 and PANSS-
positive symptoms are presented in Fig. 3. The total effect
of the college-PRSPT=0.01 on PANSS-positive score was
estimated as 0.92 (95% BCCI: −2.62, 5.08). The direct
effect was estimated to be β= 0.03 (95% BCCI: −3.57,
3.69) and the indirect effect mediated through globally
impaired ERP was estimated to be β= 0.90 (95% BCCI:
0.11, 2.24) (Fig. 3). The proportion of mediating effect
from college-PRS through globally impaired ERP to
PANSS positive was estimated at 97.1%. These results
suggest that the effect of the college-PRSPT=0.01 on
PANSS-positive score was almost entirely mediated
(a) all subjects
(b) cases with SCZ or BPD
Fig. 1 Pair-wise polygenic association analyses between globally
impaired ERP and PRS for each psychiatric or cognitive
phenotype for: (a) all subjects and (b) cases with SCZ or BPD. We
derived PRS for schizophrenia, bipolar disorder, college completion,
and childhood intelligence from each of the discovery samples with
ﬁve different P value thresholds (PTs used to select training set SNPs:
0.001, 0.01, 0.05, 0.1, and 0.5; shown with different colors) and apply
them to globally impaired ERP in (a) the entire sample and (b) those
affected by SCZ or BPD. Each pair is shown on the x-axis and the
proportion of variance explained for globally impaired ERP (estimated
via Nagelkerke’s pseudo-R²) on the y-axis. *Unadjusted P value < 0.05;
**FDR-corrected P value < 0.05 (the total number of testing for
multiple comparisons n= 20)
SCZ-PRS Globally Impaired ERP
PANSS
Posive
Top 3 PCs
of genotypes
Direct Eﬀect β=2.68 (95%CI: -0.37, 5.52) 
Indirect Eﬀect β=0.27 (95%CI: -0.34, 1.23) 
Total Eﬀect β=2.95 (95%CI: -0.16, 5.75) 
Age
Sex
CPZ equivalent dose
Current smoking
Fig. 2 Causal relationship between SCZ-PRS, globally impaired
ERP, and PANSS-positive score for patients
College-PRS Globally Impaired ERP
PANSS
Posive
Top 3 PCs
of genotypes
Direct Eﬀect β=0.03 (95%CI: -3.57, 3.69) 
Indirect Eﬀect β=0.90 (95%CI: 0.11, 2.24) 
Total Eﬀect β=0.92 (95%CI: -2.62, 5.08) 
Age
Sex
CPZ equivalent dose
Current smoking
Fig. 3 Causal relationship between college-PRS, globally
impaired ERP, and PANSS-positive score for patients
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through globally impaired ERP. Adding an
exposure–mediator interaction term did not substantially
change the effect estimates (direct effect β=−0.22 (95%
BCCI: −3.97, 3.59); indirect effect β= 1.12 (95% BCCI:
0.06, 3.34)).
Relationship between PRS, diagnosis, and globally impaired
ERP
We also examined whether the effect of any associated
PRS on globally impaired ERP is mediated through “case
vs. control status” or through one speciﬁc major mental
illness among cases (see Supplementary Results). Nearly
one-third (30.9%) of the total effect of SCZ-PRSPT=0.001
on globally impaired ERP was mediated by the presence of
psychotic illness (Figure S1a). Among cases, the propor-
tion of estimated mediating effect of “SCZ vs. BPD” on the
total effect of SCZ-PRSPT=0.001 on globally impaired ERP
was very close to zero (Figure S1b). A small proportion
(11%) of the total effect of college-PRSPT=0.01 on globally
impaired ERP was mediated by the presence of psychotic
illness (Figure S2a). For cases with psychotic illness, the
mediating effect due to having a speciﬁc diagnosis of SCZ
or BPD was estimated to be zero (Figure S2b).
Sensitivity analyses of unmeasured confounding
Sensitivity analyses of unmeasured confounding suggest
that even in the presence of strong unmeasured con-
founding, results of the above mediation analyses would
not substantially change (see Supplementary Results and
Table S5-S10). In the mediation analysis with college-PRS
as the exposure, globally impaired ERP proﬁle as the
mediator, and PANSS-positive score as the outcome,
existence of unmeasured confounding would likely lead to
overestimation of the indirect effect and underestimation
of the direct effect. Nonetheless, the estimated indirect
effect remained signiﬁcant after controlling for a strong
hypothetical confounder with correlations of 0.3 with
both mediator and outcome, and the proportion mediated
of 66.5% supported our conclusion that the majority of
the effect of college-PRSPT=0.01 on PANSS-positive score
was indirect.
Discussion
In the present study, we successfully replicated the
clustering of ERP components in an independent sample,
including a globally impaired ERP cluster (deﬁned as
having abnormalities in all six ERP measures, including
P50 sensory gating, amplitude of S1 response, N1 ampli-
tude, P2 amplitude, P3 amplitude, and P3 latency). We
also replicated our previous ﬁndings that individuals in
the globally impaired cluster exhibited greater psychotic
symptom severity than individuals in other clusters (Table
1)23. Our results showed that the globally impaired ERP
phenotype was associated with polygenic inﬂuences on
educational attainment and, to a lesser extent, schizo-
phrenia. We also observed a positive association between
education PRS and positive symptoms that was almost
entirely mediated by effects on the globally impaired ERP
phenotype.
Our results demonstrate possible polygenic pleiotropy
between SCZ and globally impaired ERP. We found that
higher SCZ polygenic risk was marginally associated
(unadjusted P value= 0.01, FDR-corrected P= 0.06) with
being in the globally impaired ERP cluster. However, there
was no observed association between BPD-PRS and the
globally impaired ERP cluster.
Although globally impaired ERP was associated with
both SCZ-PRS and PANSS-positive symptoms score,
showing potential to serve as an endophenotype for
schizophrenia, only a small proportion (9.1%) of the effect
of SCZ-PRS on PANSS-positive score was mediated by
globally impaired ERP, suggesting that ERP cluster may
not be an ideal intermediate phenotype between SCZ-
related genetic variants and positive psychotic symptoms.
In addition, we found that the relationship between SCZ-
PRS and globally impaired ERP was signiﬁcantly mediated
by the presence of psychotic illness (i.e., case vs. control
status) (see Supplementary Figure S1a), implying that the
observed association between SCZ-PRS and globally
impaired ERP may be only secondary to the effects of
SCZ-associated SNPs on the presence of psychotic illness.
The evidence for polygenic overlap was strongest for
college completion and globally impaired ERP. We found
signiﬁcant positive PRS correlations between greater
college-PRS (i.e., greater polygenic loading for higher
education) and the globally impaired cluster across all ﬁve
P value thresholds (Supplementary Table S3a), with the
strongest signal at the PRS P value threshold of 0.01,
explaining 6% of the variance in the globally impaired ERP
in the full sample (n= 383). A similar pattern of genetic
overlap was also observed between greater childhood
intelligence-PRS and being in the globally impaired clus-
ter. These results were unexpected, as cognitive impair-
ment is common among patients with SCZ and BPD and
epidemiological studies have indicated that poor school
performance and low cognitive ability are risk factors for
SCZ and BPD30–32. However, our results are compatible
with ﬁndings for BPD from the Swedish National School
Register of over 900,000 individuals showing that those
with excellent school performance had a nearly fourfold
increased risk of later BPD compared with those with
average grades36. Our results are also consistent with
recent ﬁndings examining genetic overlap between psy-
chiatric diseases and cognitive ability. Studies employing
an LD score regression approach to estimate cross-trait
genetic correlations found positive genetic correlations
between BPD/SCZ risk and educational attainment38,40.
One possible explanation for the LD score regression
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results is “case ascertainment bias,” such that patients
from more educated families were more likely to partici-
pate in research. However, in our study, we avoided such
case ascertainment bias by using an objective physiolo-
gical phenotype, which was not phenotypically associated
with years of education, and found a signiﬁcant positive
genetic correlation between this psychosis-related trait
and higher educational attainment. Further research is
needed to replicate and explain the counterintuitive
genetic correlation between higher educational attain-
ment and globally impaired ERP.
We found that the effect of the college-PRSPT=0.01 on
PANSS-positive score was almost entirely mediated
through globally impaired ERP membership (Fig. 3). It has
been suggested that a dimensional classiﬁcation of psy-
chopathology among patients with SCZ and BPD can
better reﬂect the underlying genetic variation;2 therefore,
PANSS scores have been used in genetic research to
identify the genetic underpinning of speciﬁc symptom
dimensions of psychotic illness72. However, the major
disadvantage of using speciﬁc symptom-domain scores
(e.g., PANSS scores) as the phenotype is that they are very
likely to be inﬂuenced by treatment, stage of illness, and
other environmental factors. Globally impaired ERP as an
intermediate phenotype of positive symptoms may be less
likely to be inﬂuenced by clinical or environmental fac-
tors. The nearly complete mediation of the association
between college-PRS and PANSS positive by globally
impaired ERP implies that the globally impaired ERP may
represent some aspects of brain physiology linking higher
education-associated alleles and positive psychotic
symptoms. By contrast, only a small proportion of the
relationship between SCZ-PRS and PANSS-positive score
was mediated by globally impaired ERP. It is possible that
SNPs affecting positive symptom severity partially overlap
with both SCZ-associated and education-associated SNPs,
and globally impaired ERP may capture the component of
positive symptoms that is genetically correlated with
educational attainment. Thus, globally impaired ERP may
help stratify the genetic components of psychotic symp-
toms (see Supplementary Figure S5).
The present study has several limitations. First, the PRS
approach assumes a linear additive model and does not
consider gene–gene interactions that may contribute to
the underlying genetic architecture of the phenotypes of
interest. Second, the effect estimates from the mediation
analyses might be biased due to violation of the unmea-
sured confounding assumption67. However, our sensitivity
analyses suggest that even with the existence of a strong
unmeasured confounder for the mediator–outcome rela-
tionship, the results of mediation analyses remained
robust. Third, our analyses were restricted to individuals
of European ancestry, thus limiting the generalizability of
the ﬁndings to other ethnic populations. Future research
should include a broader range of ethnic populations.
Finally, although the causal mediation relationship iden-
tiﬁed by a statistical approach may imply a mechanistic
causality, the true mechanisms governing the processes
from exposure to outcome can only be understood by
considering the sufﬁcient cause model (i.e., the identiﬁ-
cation of a set of minimal conditions that inevitably
produce outcome). To look into the black box of causal
mechanisms, closer observations, more detailed and
extensive data, and more scientiﬁc knowledge will be
needed.
Conclusion
This is the ﬁrst study, to our knowledge, to demonstrate
a potential link between genetic risk scores, ERP pheno-
type, and positive psychotic symptoms. The results also
support prior evidence that college education, a proxy for
adolescent and young adult cognitive ability, is genetically
correlated with psychotic illness, and suggest a potential
physiological role for the multivariate ERP proﬁle in the
genetic link between cognitive ability and psychotic
symptoms.
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